共 66 条
[1]
Ferlay J(2010)Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer. 127 2893-2917
[2]
Shin HR(2014)Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy Surg Today. 44 11-21
[3]
Bray F(2012)Gastrointestinal cancer: adjuvant chemotherapy after D2 gastrectomy for gastric cancer Nat Rev Clin Oncol. 9 192-194
[4]
Forman D(2007)Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med. 357 1810-1820
[5]
Mathers C(2011)Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer J Clin Oncol. 29 4387-4393
[6]
Parkin DM(2012)Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Lancet. 379 315-321
[7]
Yoshikawa T(2011)Guidelines for the management of oesophageal and gastric cancer Gut. 60 1449-1472
[8]
Rino Y(2007)Imaging in local staging of gastric cancer: a systematic review J Clin Oncol. 25 2107-2116
[9]
Yukawa N(2009)Imaging in assessing lymph node status in gastric cancer Gastric Cancer. 12 6-22
[10]
Oshima T(1999)Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma J Clin Oncol. 17 2403-2411

